What’s New in Alzheimer’s Disease Clinical Trials?
Judy Heidebrink, M.D., M.S., Richard D. and Katherine M. O'Connor Research Professor of Neurology at University of Michigan Medical School, and Director, Cognitive Disorders Clinic, University of Michigan – Health
▶︎
Dr. Jeffrey Cummings - Alzheimer's Clinical Trials: History & Lessons
▶︎
Alzheimer's Disease - Amyloidopathy (Part 2)
▶︎
Webinar: USP 922 Water Activity — What Pharmaceutical Manufacturers Need to Know
▶︎
From Global Travel to Local Triage: Practical Infectious Disease Preparedness for #WorldCup2026
▶︎
The Latest in Alzheimer’s Research
▶︎
Int'l Neuroblastoma Webinar Series Session #18: BCC Clinical Trials Update with Dr. Giselle Sholler
▶︎
Emerging Trends in Epilepsy Research & Management
▶︎
Frontiers in Cell & Gene Therapy and Regenerative Medicine - Terrence R. Flotte, MD (4/08/2026)
▶︎
Management of Common Infections & Management of MDROs in Long Term Care.
▶︎
What’s New in Alzheimer’s Disease Clinical Trials
▶︎
Genetics of Alzheimer's Disease
▶︎
Leqembi & Kisunla: New Alzheimer's Treatments Explained | Dr. Armen J. Moughamian
▶︎
2026 CDG Miniseries | Gene Editing in Rare Diseases | Dr. Rebecca Ahrens-Nicklas | Episode TEN
▶︎
Gastrointestinal Monitoring in the Osteoarthritis Patient - VOACON 2026
▶︎
Reverse Alzheimer's? This (Viral) Harvard Doctor Explains the Truth
▶︎
Get in the kNOw: Nocardia Management in Solid Organ Transplant Recipients
▶︎
Alzheimer's Disease - The amyloid cascade, alternative mechanisms (Part 1)
▶︎
CHW Diabetes Learning Modules | IPhA Education Series
▶︎
Controversies in Dementia Research | Webinar
▶︎